Jun 09, 2021 / 07:50PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Good afternoon, everyone. I'm Matt Sykes, Senior Research Analyst for Life Science Tools & Diagnostics at Goldman. And I have the pleasure of welcoming the 10x Genomics management team to present to us today. We have Serge Saxonov, the Chief Executive Officer; and Justin McAnear, the Chief Financial Officer. Serge, Justin, thanks so much for being here. We really appreciate it.
Serge Saxonov - 10x Genomics, Inc. - Co-Founder, CEO & Director
Thanks for having us. Thank you.
Questions and Answers:
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research AnalystMaybe I'll turn it over to your first, Serge, to kind of set the stage a little bit, talk about maybe the most recent quarter, expectations for the year, but just also some of the key drivers and things that you want to -- can be top of mind for investors for 10x?
Serge Saxonov - 10x Genomics, Inc. - Co
Trustpilot
